Nelson Dusetti: Grateful for Canceropôle Provence-Alpes-Côte d’Azur support
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at CRCM shared a post on LinkedIn:
Grateful for Canceropôle Provence-Alpes-Côte d’Azur Support!
We are honored to have been awarded by Canceropôle Provence-Alpes-Côte d’Azur in 2024! This funded initiative aims to deepen understanding of chemoresistance mechanisms and refine predictive models for chemotherapy response, with the goal of improving personalized treatment strategies for pancreatic cancer.
I am also thrilled to share this recognition with my friend and colleague Sylvain Garciaz (IPC, Marseille), who has been awarded for his “TapeStream” project. His work focuses on studying minimal residual disease in acute myeloid leukemia using single-cell sequencing with TAPESTRI technology in patients undergoing intensive chemotherapy.
We sincerely thank Canceropôle Provence-Alpes-Côte d’Azur for its continuous support and for driving impactful research at CRCM – Centre de Recherche en Cancérologie de Marseille and Institut Paoli-Calmettes, fostering innovation in translational oncology and enabling scientific advances that bring us closer to more effective treatments.
Looking forward to the progress ahead!
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023